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Abbreviation Full Name 
7SK snRNP  7SK small nuclear ribonucleoprotein, HEXIM1/7SK
P-TEFb 
Act D Actinomycin D 
CAK CDK-activating kinase 
Cal A Calyculin A 
CaM calmodulin 
CaMK calmodulin dependent kinase 
CaMKK calmodulin-dependent protein kinase kinase 
CBP CREB-binding protein 
CIP Calf intestinal alkaline phosphatase 
CKI Cyclin-dependent kinase inhibitor 
CLP-1 Cardiac lineage protein-1 
CnB Calcineurin B 
CREB cAMP response element binding protein 
CsA Cyclosporine A 
CTD C-terminal domain 
DFO Desferrioxamine 
DRB 5,6-dichloro-1-b-D-ribofuranosyl-benzimidazole 
DSIF DRB-sensitivity inducing factor 
ERα Estrogen receptor alpha 
GMCSF Granulocyte-macrophage colony-stimulating factor 
GPCR G-protein-coupled receptor 
GR Glucocorticoid receptor 
GSK3β Glycogen synthase kinase-3β 
GTF General transcription factor 
HDAC Histone deacetylase 














HIV-1 Human immunodeficiency virus type 1 
HMBA Hexamethylene bisacetamide  
HU Hydroxyurea 
IGF-I Insulin-like growth factor-I 
JNK C-Jun N-terminal kinase 
LTCC L-type calcium channels 
LTR Long terminal repeats 
MAPK Mitogen-activated protein kinase 
MAT1 Ménage a trois 
MCLR Microcystin LR 
MEF2 Myocyte enhancer binding factor 2 
MELC Murine erythroleukemia cell 
MLR Microcystin-LR 
MMP Matrix metalloproteinase 
mTOR Mammalian target of rapamycin 
Myr-AKT Myristoylation signal-attached Akt 
NCS Neocarzinostatin 
NELF Negative elongation factor 
NFAT Nuclear factor of activated T cells 
NRF-1 Nuclear respiratory factor 1 
NTEF Negative transcription elongation factor 
PAPP Potato acid phosphatase 
PDK1 Phosphoinositide-dependent kinase-1 
PH Pleckstrin-homology  
PI3K Phosphoinositide-3 kinase 
PIC Preinitiation complex 
PKA cAMP-dependent protein kinase 
PKB Protein kinase B 
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PKC Protein kinase C 
Pol II RNA polymerase II 
PP1α Protein phosphatase 1α 
PP2B / CaN Calcineurin 
PP2B CA Constitutively active form of calcineurin A 
PP2B IN Catalytically inactive mutant of calcineurin A 
PtdIns(4,5)P2 Phosphatidylinositol-4,5-bisphosphate 
PtdIns(3,4,5)P3 Phosphatidylinositol-3,4,5-trisphosphate 
P-TEFb  Positive transcription elongation factor b 
S6K1 S6 kinase-1 
SKIP Splicing-associated c-Ski-interacting protein 
snRNP Small nuclear ribonucleoprotein particle 
TAR Transacting-response 
TBP TATA box-binding protein 
TEC Transcript elongation complex 
TF II (D, B, E, F, & H) Transcription factor II (D, B, E, F, & H) 
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